Cooley LLP is serving as legal counsel to BioMarin, Goodwin Procter LLP is serving as legal counsel to Inozyme, while Skadden is advising Centerview Partners LLC...
BioMarin’s Acquisition of Inozyme Pharma
Merck’s $3.9 Billion Acquisition of SpringWorks Therapeutics
Sullivan & Cromwell advised Merck KGaA, Darmstadt, Germany, while Goodwin Procter advised SpringWorks Therapeutics on the transaction. Skadden advised Centerview Partners and Goldman Sachs & Co....
Jazz Pharmaceuticals’ $935 Million Acquisition of Chimerix
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to Jazz, while Skadden and Cooley are advising Chimerix on the deal. Jazz Pharmaceuticals plc and...
Emerson’s $7.2 Billion Acquisition of Remaining Outstanding Shares of AspenTech
Davis Polk & Wardwell is serving as legal advisor to Emerson, while Skadden, Arps, Slate, Meagher & Flom is serving as legal counsel to the AspenTech...
Aptean’s Acquisition of Logility
Orrick is advising Aptean, Jones Day is advising Logility Supply Chain Solutions, while Skadden is advising Lazard as financial advisor to Logility. Aptean, a global provider...
Johnson & Johnson’s Acquisition of Intra-Cellular Therapies
Cravath is representing Johnson & Johnson, Davis Polk & Wardwell is serving as legal advisor to Intra-Cellular Therapies, and Skadden is representing Centerview Partners LLC and...
Johnson & Johnson’s Acquisition of Intra-Cellular Therapies
Cravath is representing Johnson & Johnson, Davis Polk & Wardwell is serving as legal advisor to Intra-Cellular Therapies, and Skadden is representing Centerview Partners LLC and...
Quanterix’s Acquisition of Akoya Biosciences
Covington & Burling represented Quanterix Corporation, and DLA Piper represented Akoya Biosciences in the transaction. Skadden represented Goldman Sachs & Co. LLC as financial advisor to...
Pharmacosmos Group’s Acquisition of G1 Therapeutics
Arnold & Porter Kaye Scholer advised Pharmacosmos, while Ropes & Gray and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. represented G1 Therapeutics on the deal....
TowerBrook and CD&R’s $8.9 Billion Acquisition R1 RCM
Kirkland & Ellis is advising R1 RCM, Skadden is advising a special committee of the R1 RCM Inc. in the transaction, while Wachtell, Lipton, Rosen &...
Merck’s Acquisition of Eyebiotech
Skadden advised Eyebiotech Limited, while Gibson, Dunn & Crutcher advised Merck the deal. Merck, known as MSD outside of the United States and Canada, and Eyebiotech...
Vertex Pharmaceuticals’ Acquisition of Alpine Immune Sciences
Skadden advised Vertex Pharmaceuticals Incorporated, while Fenwick & West advised Alpine in the transaction. Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. have entered into a definitive...